ليست عنوان مقالات لاتين Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: II. Developmental Toxicity Evaluation in Rats and Rabbits Salen complex of Cu(II) supported on superparamagnetic Fe3O4@SiO2 nanoparticles: An efficient and recyclable catalyst for synthesis of 1- and 5-substituted 1H-tetrazoles

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: II. Developmental Toxicity Evaluation in Rats and Rabbits

2

Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: III. Single-Generation Rat Reproduction Study

3

Safety Assessment of DHA-Rich Microalgae from Schizochytrium sp.: IV. Mutagenicity Studies

4

Safety assessment of diacylglycerol oil as an edible oil: A review of the published literature

5

Safety assessment of dietary administered paprika color in combined chronic toxicity and carcinogenicity studies using F344 rats

6

Safety assessment of dietary bamboo charcoal powder: A 90-day subchronic oral toxicity and mutagenicity studies

7

Safety assessment of dietary diacylglycerol oil: A two-generation reproductive toxicity study in rats

8

Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats

9

Safety assessment of energy fluxes on in-vessel components with SAFALY

10

Safety assessment of envisaged systems for automotive hydrogen supply and utilization

11

Safety assessment of EPA-rich oil produced from yeast: Results of a 90-day subchronic toxicity study

12

Safety assessment of EPA-rich triglyceride oil produced from yeast: Genotoxicity and 28-day oral toxicity in rats

13

Safety assessment of esters of p-hydroxybenzoic acid (parabens)

14

Safety assessment of food and feed from biotechnology-derived crops employing RNA-mediated gene regulation to achieve desired traits: A scientific review

15

Safety assessment of gamma-glutamylcysteine sodium salt

16

Safety assessment of genetically modified rice expressing human serum albumin from urine metabonomics and fecal bacterial profile

17

Safety assessment of glycol recovery unit in a gas refinery by failure mode and effects analysis technique

18

Safety assessment of greenhouse hydroponic tomatoes irrigated with reclaimed and surface water

19

Safety assessment of heated diacylglycerol oil: Subchronic toxicity study in rats

20

Safety assessment of heat-sterilized green tea catechin preparation: A 6-month repeat-dose study in rats

21

Safety assessment of hydroxypropyl methylcellulose as a food ingredient

22

Safety assessment of iron EDTA [sodium iron (Fe3+) ethylenediaminetetraacetic acid]: summary of toxicological, fortification and exposure data

23

Safety assessment of kola nut extract as a food ingredient

24

Safety assessment of Lactobacillus brevis KB290 as a probiotic strain

25

Safety Assessment of Lactobacillus paracasei IBRC-M 11110 in Wistar rats: a subacute 28-day toxicity study

26

Safety assessment of Lactobacillus plantarum JDM1 based on the complete genome

27

Safety assessment of Lactobacillus strains: Presence of putative risk factors in faecal, blood and probiotic isolates

28

Safety assessment of lutein and zeaxanthin (Lutemax™ 2020): Subchronic toxicity and mutagenicity studies

29

Safety assessment of meat from transgenic cattle by 90-day feeding study in rats

30

Safety assessment of melinjo (Gnetum gnemon L.) seed extract: Acute and subchronic toxicity studies

31

Safety Assessment of Mentha mozaffarianii Essential Oil: Acute and Repeated Toxicity Studies

32

Safety assessment of methanol extract of red dragon fruit (Hylocereus polyrhizus): Acute and subchronic toxicity studies

33

Safety assessment of mushroom β-glucan: Subchronic toxicity in rodents and mutagenicity studies

34

Safety assessment of myristic acid as a food ingredient

35

Safety assessment of N-acetyl-l-threonine

36

Safety Assessment of Neoadjuvant Pertuzumab Combined with Trastuzumab in Nonmetastatic HER2-Positive Breast Cancer in Postmenopausal Elderly Women of South Asia

37

Safety Assessment of Ocimum Basilicum Hydroalcoholic Extract in Wistar Rats: Acute and Subchronic Toxicity Studies

38

Safety assessment of offshore structure

39

Safety Assessment of Osthole Isolated from Prangos ferulacea: Acute and Subchronic Toxicities and Modulation of Cytochrome P450

40

safety assessment of osthole isolated from prangos ferulacea: acute and subchronic toxicities and modulation of cytochrome p450

41

Safety assessment of people in public building fire incidents using harmony search algorithm

42

Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease

43

Safety assessment of pipes with multiple local wall thinning defects under pressure and bending moment

44

Safety assessment of polylactide (PLA) for use as a food-contact polymer

45

Safety assessment of pomegranate fruit extract: Acute and subchronic toxicity studies

46

Safety assessment of potential probiotic lactic acid bacterial strains Lactobacillus rhamnosus HN001, Lb. acidophilus HN017, and Bifidobacterium lactis HN019 in BALB/c mice

47

Safety assessment of propyl paraben: a review of the published literature

48

Safety assessment of rice bran oil in a chicken embryo model

49

Safety assessment of sandalwood oil (Santalum album L.)

50

Safety assessment of SDA soybean oil: Results of a 28-day gavage study and a 90-day/one generation reproduction feeding study in rats

51

Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: The ASSENT-1 trial, , ,

52

Safety assessment of smoked fish related to Listeria monocytogenes prevalence using risk management metrics

53

Safety assessment of steel-plate girder bridges subjected to military load classification

54

Safety assessment of structures in view of fuzzy randomness

55

Safety assessment of Syzygium aromaticum flower bud (clove) extract with respect to testicular function in mice

56

Safety assessment of the butyrate-producing Butyricicoccus pullicaecorum strain 25-3T, a potential probiotic for patients with inflammatory bowel disease, based on oral toxicity tests and whole genome sequencing

57

Safety assessment of the commensal strain Bacteroides xylanisolvens DSM 23964

58

Safety assessment of the fermented Phylloporia ribis (Lonicera japonica Thunb.) mycelia by oral acute toxicity study in mice and 90-day feeding study in rats

59

Safety assessment of the lithium target of the international fusion materials irradiation facility

60

Safety assessment of the post-harvest treatment of button mushrooms (Agaricus bisporus) using ultraviolet light

61

Safety assessment of the Quercus brantii gall hydroalcoholic extract: Single and repeated oral dose toxicity studies

62

Safety assessment of transgenic Bacillus thuringiensis with VIP insecticidal protein gene by feeding studies

63

Safety assessment of two advanced ferritic steel molten salt blanket design concepts

64

Safety assessment of unignited hydrogen discharge from onboard storage in garages with low levels of natural ventilation

65

Safety assessment of yerba mate (Ilex paraguariensis) dried extract: Results of acute and 90 days subchronic toxicity studies in rats and rabbits

66

Safety assessment of Ylang–Ylang (Cananga spp.) as a food ingredient

67

Safety Assessment of Zanjan Drinking Water System Using Water Safety Plan

68

Safety assessment of Zanthoxylum alatum Roxb. essential oil, its antifungal, antiaflatoxin, antioxidant activity and efficacy as antimicrobial in preservation of Piper nigrum L. fruits

69

Safety assessment of β-nitropropionic acid: a monograph in support of an acceptable daily intake in humans

70

Safety assessment of γ-cyclodextrin

71

Safety assurance via on-line monitoring

72

Safety at sea and fisheries management:: fishermenʹs attitudes and the need for co-management

73

Safety at the Racetrack: Results of Restrictor Plates in Superspeedway Competition

74

Safety Attitude and Its Associated Factors among Workers in Micro- and Small-Scale Enterprises (MSSEs) in Shiraz

75

Safety Attitude and Its Predictor Individual and Organizational Variables among Nurses: A Cross-Sectional Study

76

Safety Attitudes among Nurses and Its Relation with Occupational Accidents: A Questionnaire Based Survey

77

Safety Based Cross Sectional Study of Infrastructure and Associated Problems among Undeveloped Neighborhoods

78

Safety becomes danger: dilemmas of drug-use in public space

79

Safety behaviors and dysfunctional beliefs about sleep: Testing a cognitive model of the maintenance of insomnia

80

Safety behaviors and sleep effort predict sleep disturbance and fatigue in an outpatient sample with anxiety and depressive disorders

81

Safety behaviour does not necessarily interfere with exposure therapy

82

Safety behaviour: A reconsideration

83

Safety beliefs and safe behavior among midwestern college students

84

Safety belt nonuse by internal medicine patients: A missed opportunity in clinical preventive medicine

85

Safety by design: An engineerʹs responsibility for safety : Edited by Sue Cox, Published by the Hazards Forum, London, 1996, 149 pages, ISBN 0952 5103-1-6

86

Safety by Uninterpreted Locks

87

Safety certification of airborne software: An empirical study

88

Safety certification of airborne software: An empirical study

89

Safety Challenges in Psychiatric Departments from Nurses’ Perspective: A Qualitative Study

90

Safety characteristics of lithium alloy/metal sulfide batteries

91

Safety characteristics of rechargeable lithium metal cells

92

Safety characteristics of the multipurpose fast reactor (MPFR)

93

Safety checking in an automatic train operation system

94

Safety classification of the ITER fusion power shutdown system and resulting safety requirements

95

96

Safety climate and attitude as evaluation measures of organizational safety

97

Safety climate and safety performance among construction workers in Hong Kong: The role of psychological strains as mediators

98

Safety climate and self-reported injury: Assessing the mediating role of employee safety control

99

Safety climate differences among job positions in a nuclear decommissioning and demolition industry: Employees’ self-reported safety attitudes and perceptions

100

Safety climate factors, group differences and safety behaviour in road construction

101

Safety climate in university and college laboratories: Impact of organizational and individual factors

102

Safety climate, attitudes and risk perception in Norsk Hydro

103

Safety climate, nursing organizational culture and the intention to report medication errors: A cross-sectional study of hospital nurses

104

Safety climate, safety management practice and safety performance in offshore environments

105

Safety communications: Warnings

106

Safety concept for hazards caused by ice avalanches from the Whymper hanging glacier in the Mont Blanc Massif

107

Safety concept of the IFMIF/EVEDA lithium test loop

108

Safety concerns about digoxin after acute myocardial infarction Original Research Article

109

Safety concerns about kava

110

Safety concerns about kava not unique

111

Safety concerns in ultrahigh pressure capillary liquid chromatography using air-driven pumps

112

Safety concerns over antipsychotic drug, sertindole

113

Safety concerns to application of graphene compounds in pharmacy and medicine

114

Safety conditions in manholes in the vicinity of substations

115

Safety conscious planning in small and medium-sized MPOs and rural planning agencies: Results of a domestic scan

116

Safety consciousness: Assignments that expand focus beyond the bedside

117

SAFETY CONSIDERATIONS FOR CORE MANAGEMENT AND FUEL HANDLING FOR RESEARCH REACTORS

118

Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion

119

Safety considerations for the aging workforce

120

Safety considerations in large-volume lipoplasty

121

Safety considerations in the pharmacological management of atrial fibrillation

122

Safety considerations of aerial systems using insulated and covered wire and cable

123

Safety Considerations of Laparoscopic Surgeries for Anesthesiologists During COVID-19 Pandemic?

124

Safety Considerations on MRI Systems for Firefighters and Paramedics

125

Safety considerations when placing a person with tools in an air gap to change porcelain and glass insulators on transmission systems of 345 kV and above, using ladder and aerial lift methods

126

Safety constraints applied to an adaptive Bayesian condition-based maintenance optimization model

127

Safety constraints applied to an adaptive Bayesian condition-based maintenance optimization model

128

Safety Controversies in Tooth Bleaching

129

Safety cost of a large scale hydrogen system for photovoltaic energy regulation

130

Safety criteria and quality control of HTTR fuel

131

Safety criteria and quality control of HTTR fuel Original Research Article

132

Safety Cultural Assessment among Management, Supervisory and Worker Groups in a Tar Refinery Plant

133

Safety culture and accident risk control: Perceptions of professional divers and offshore workers

134

Safety culture and behavioral change at the workplace

135

Safety culture and hazard risk perception of Australian and New Zealand maritime pilots

136

Safety Culture and Resilience in a Petrochemical Industry

137

Safety culture and safety management aboard tankers

138

Safety culture and safety management aboard tankers

139

Safety culture enhancement through the implementation of IAEA guidelines

140

Safety culture enhancement through the implementation of IAEA guidelines

141

Safety culture in GolGohar Mine in Southeast Iran in 2014

142

Safety culture in railway maintenance

143

Safety culture in Swedish air traffic control

144

Safety culture: a survey of the state-of-the-art

145

Safety culture: a survey of the state-of-the-art

146

Safety culture: Analysis of the causal relationships between its key dimensions

147

Safety design for ITER and fusion power reactors

148

Safety design of compressed hydrogen trailers with composite cylinders

149

Safety design of next generation SUI of CANDU stations

150

Safety design of radiation shielding for JT-60SA

151

Safety design of steel beams with time-dependent stability

152

Safety design: Towards a new philosophy

153

Safety determination for the use of bovine milk-derived lactoferrin as a component of an antimicrobial beef carcass spray

154

Safety diagnosis criteria—development and testing

155

Safety diagnosis in industrial work settings: The safety diagnosis questionnaire

156

Safety distance between underground natural gas and water pipeline facilities

157

Safety distances: Definition and values

158

Safety effects of roundabouts in Flanders: Signal type, speed limits and vulnerable road users

159

Safety equipment handbook: a practical guide to pesticide safety requirements: BCPC publications, Berks, 2002, 80pp., price £10, ISBN 1 901396 06 1

160

Safety estimation of structural systems via interval analysis

161

Safety Evaluation and Confidence Intervals When the Number of Observed Events Is Small or Zero, ,

162

Safety evaluation and fluorine concentration of puʹer brick tea and bianxiao brick tea

163

Safety evaluation and nutritional composition of a Fraxinus excelsior seed extract, FraxiPure™

164

Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for Humans

165

Safety evaluation of 1,4-α-glucan branching enzymes from Bacillus stearothermophilus and Aquifex aeolicus expressed in Bacillus subtilis

166

Safety evaluation of 70 MPa-capacity type III hydrogen pressure vessel considering material degradation of composites due to temperature rise

167

Safety evaluation of a glucanase preparation intended for use in food including a subchronic study in rats and mutagenicity studies

168

Safety evaluation of a hexose oxidase expressed in Hansenula polymorpha

169

Safety evaluation of a high lipid Whole Algalin Flour (WAF) from Chlorella protothecoides

170

Safety evaluation of a high-lipid algal biomass from Chlorella protothecoides

171

Safety evaluation of a lactase enzyme preparation derived from Kluyveromyces lactis

172

Safety evaluation of a lipase enzyme (BD29241 Palmitase) preparation, expressed in Pseudomonas fluorescens, intended for removing palmitic acid from triacylglycerol

173

Safety evaluation of a lipase enzyme preparation, expressed in Pichia pastoris, intended for use in the degumming of edible vegetable oil

174

Safety evaluation of a lipase expressed in aspergillus oryzae

175

Safety evaluation of a medium- and long-chain triacylglycerol oil produced from medium-chain triacylglycerols and edible vegetable oil

176

Safety evaluation of a milk basic protein fraction

177

Safety evaluation of a natural eggshell membrane-derived product

178

Safety evaluation of a natural tomato oleoresin extract derived from food-processing tomatoes

179

Safety evaluation of a novel whitening gel, containing 6% hydrogen peroxide and a commercially available whitening gel containing 18% carbamide peroxide in an exaggerated use clinical study

180

Safety evaluation of a phytase, expressed in Schizosaccharomyces pombe, intended for use in animal feed

181

Safety evaluation of a standardized phytochemical composition extracted from Bacopa monnieri in Sprague–Dawley rats

182

Safety evaluation of a thermolysin enzyme produced from Geobacillus stearothermophilus

183

Safety evaluation of a triterpenoid-rich extract from bamboo shavings

184

Safety evaluation of a xylanase expressed in Bacillus subtilis

185

Safety evaluation of Algal Oil from Schizochytrium sp.

186

Safety Evaluation of Amino Peptidase Enzyme Preparation derived from Aspergillus niger

187

Safety evaluation of amylomaltase from Thermus aquaticus

188

Safety evaluation of an artificial groundwater recharge system for reclaimed water reuse based on bioassays Original Research Article

189

Safety evaluation of an enzymatically-synthesized glycogen (ESG)

190

Safety evaluation of an extract from Salacia oblonga

191

Safety evaluation of an IPP tripeptide-containing milk protein hydrolysate

192

Safety evaluation of an α-amylase enzyme preparation derived from the archaeal order Thermococcales as expressed in Pseudomonas fluorescens biovar I

193

Safety evaluation of an α-cyclodextrin glycosyltranferase preparation

194

Safety Evaluation of Aqueous Extract of Garcinia Kola Seeds in Male Wistar Rats

195

Safety evaluation of arachidonic acid rich Mortierella alpina biomass in albino rats—A subchronic study

196

Safety evaluation of biological drugs: What are toxicology studies in primates telling us?

197

Safety evaluation of certain contaminants in food

198

Safety evaluation of certain food additives

199

Safety evaluation of certain food additives and contaminants: Prepared by the fifty-seventh meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series 48, WHO, Geneva, 2002, International Programme on Chemical Safet

200

Safety evaluation of certain food additives and contaminants: Prepared by the Fifty-third meeting of the joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series: 44; WHO, Geneva, 2000, IPCS – International Programme on Chemical

201

Safety evaluation of certain food additives: Prepared by the fifty-first meeting of the joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series 42; WHO, Geneva, 1999, IPCS-International Programme on Chemical Safety, 490 pages;

202

Safety Evaluation of Certain Food Additives: Prepared by the Fifty-Ninth Meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series: 50; International Programme on Chemical Safety, IPCS, WHO, Geneva, 2003, vi+425 pa

203

Safety evaluation of certain mycotoxins in food: Prepared by the fifty-sixth meeting of the joint FAO/WHO Expert Committee on Food Additives (JECFA). WHO Food Additives Series: 47; FAO Food and Nutrition Paper: 74; IPCS-International Programme on Chemical

204

Safety evaluation of chicken breast extract containing carnosine and anserine

205

Safety evaluation of chloramine –T on ornamental zebra fish (Danio rerio) using LC50 calculation and organ pathology

206

Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers

207

Safety evaluation of daidzein in laying hens: Part I. Effects on laying performance, clinical blood parameters, and organs development

208

Safety evaluation of daidzein in laying hens: Part II. Effects on calcium-related metabolism

209

Safety evaluation of DHA-rich Algal Oil from Schizochytrium sp.

210

Safety Evaluation of Dietary Aluminum

211

Safety Evaluation of Doogh, a Traditional Iranian Dairy Product, in Khuzestan, Iran: A Cross-Sectional Study on Microbiological, Chemical and Toxicological Aspects

212

Safety evaluation of Elsholtzia splendens extracts: Assessment of acute toxicity and mutagenicity

213

Safety evaluation of EvesseTM EPC, an apple polyphenol extract rich in flavan-3-ols

214

Safety Evaluation of Ferrous Bisglycinate Chelate

215

Safety evaluation of fibermalt

216

Safety evaluation of formulations containing carboxymethyl derivatives of starch and chitosan in albino rats

217

Safety evaluation of functional ingredients

218

Safety evaluation of gas storage caverns located close to a tectonic fault

219

Safety evaluation of glucose oxidase from Penicillium chrysogenum

220

Safety evaluation of highly-branched cyclic dextrin and a 1,4-α-glucan branching enzyme from Bacillus stearothermophilus

221

Safety evaluation of highway geometric design criteria in horizontal curves at downgrades

222

Safety evaluation of human accidents in coal mine based on ant colony optimization and SVM

223

Safety evaluation of ice-structuring protein (ISP) type III HPLC 12 preparation. Lack of genotoxicity and subchronic toxicity

224

Safety evaluation of Lactobacillus pentosus strain b240

225

Safety evaluation of lipase derived from Rhizopus oryzae: Summary of toxicological data

226

Safety Evaluation of Lipase Produced from Candida rugosa: Summary of Toxicological Data

227

Safety evaluation of lipase produced from Rhizopus oryzae: summary of toxicological data

228

Safety evaluation of longan seed extract: Acute and repeated oral administration

229

Safety Evaluation of Low-Rise Steel Structures under Wind Loads by Nonlinear Database-Assisted Technique

230

Safety Evaluation of Mangifera Indica Bark for Raw Water Purification

231

Safety evaluation of meso-zeaxanthin

232

Safety evaluation of Monascus purpureus red mould rice in albino rats

233

Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory Adjuvant

234

Safety evaluation of Mucor rouxii CFR-G15 biomass containing ω-6 fatty acids in rats

235

Safety Evaluation of Nano Iron Zero Valente Green Synthesized: A Comparative Study

236

Safety evaluation of nano/sub-microsized lignan glycosides from sesame meal

237

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (SinaAmpholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis

238

Safety evaluation of nonthermal atmospheric pressure plasma liquid treatment: Single DNA molecule-based method

239

Safety evaluation of Nostoc flagelliforme (nostocales, cyanophyceae) as a potential food

240

Safety evaluation of oleic-rich triglyceride oil produced by a heterotrophic microalgal fermentation process

241

Safety evaluation of oligofructose: 13 Week rat study and in vitro mutagenicity

242

Safety evaluation of pectin-derived acidic oligosaccharides (pAOS): Genotoxicity and sub-chronic studies

243

Safety evaluation of perfluoropolyethers, liquid polymers used in barrier creams and other skin-care products

244

Safety evaluation of phosphodiesterase derived from Leptographium procerum

245

Safety Evaluation of Phosphodiesterase Produced from Penicillium citrinum: Summary of Toxicological Data

246

Safety evaluation of phytosterol esters. Part 1. Assessment of oestrogenicity using a combination of in vivo and in vitro assays

247

Safety Evaluation of Phytosterol Esters. Part 2. Subchronic 90-Day Oral Toxicity Study on Phytosterol Esters–A Novel Functional Food

248

Safety Evaluation of Phytosterol Esters. Part 3. Two-Generation Reproduction Study in Rats with Phytosterol Esters—a Novel Functional Food

249

Safety Evaluation of Phytosterol Esters. Part 4. Faecal Concentrations of Bile Acids and Neutral Sterols in Healthy Normolipidaemic Volunteers Consuming a Controlled Diet either with or without a Phytosterol Ester-enriched Margarine

250

Safety evaluation of phytosterol esters. Part 5. Faecal short-chain fatty acid and microflora content, faecal bacterial enzyme activity and serum female sex hormones in healthy normolipidaemic volunteers consuming a controlled diet either with or without

251

Safety evaluation of phytosterol esters. Part 7. Assessment of mutagenic activity of phytosterols, phytosterol esters and the cholesterol derivative, 4-cholesten-3-one

252

Safety evaluation of phytosterol esters. Part 8. Lack of genotoxicity and subchronic toxicity with phytosterol oxides

253

Safety evaluation of phytosterol-esters. Part 9: Results of a European post-launch monitoring programme

254

Safety evaluation of Phytovagex, a pessary formulation of Nigella sativa, on pregnant rats

255

Safety evaluation of pigment containing Aspergillus carbonarius biomass in albino rats

256

Safety evaluation of polydextrose in infant formula using a suckling piglet model

257

Safety evaluation of polyphenols extracted from hop bracts

258

Safety Evaluation of Primary-Side Bleed-and-Feed Scenarios by an Experimental Loss of Feedwater Event at the IIST Facility

259

Safety evaluation of proanthocyanidin polymer-rich fraction obtained from stem bark of Stryphnodendron adstringens (BARBATIMأO) for use as a pharmacological agent

260

Safety evaluation of proanthocyanidin-rich extract from grape seeds

261

Safety evaluation of Propionibacterium freudenreichii ET-3 culture

262

Safety evaluation of protein of silkworm (Antheraea pernyi) pupae

263

Safety evaluation of saffron stigma (Crocus sativus L.) aqueous extract and crocin in patients with schizophrenia

264

Safety evaluation of shallow tunnel based on elastoplastic-viscoplastic analysis

265

Safety evaluation of short-term exposure to chitooligomers from enzymic preparation

266

Safety evaluation of slender high-strength concrete columns under sustained loads

267

Safety evaluation of small-break LOCA with various locations and sizes for SMART adopting fully passive safety system using MARS code

268

Safety evaluation of some wild plants in the New Nordic Diet

269

Safety evaluation of sources of docosahexaenoic acid and arachidonic acid for use in infant formulas in newborn piglets

270

Safety evaluation of steroidal saponin DT-13 isolated from the tuber of Liriope muscari (Decne.) Baily

271

Safety evaluation of superabsorbent baby diapers

272

Safety evaluation of table liner for vertical roller mill by modified fatigue limit

273

Safety evaluation of tannase enzyme preparation derived from Aspergillus oryzae

274

Safety evaluation of the double mutant 5-enol pyruvylshikimate-3-phosphate synthase (2mEPSPS) from maize that confers tolerance to glyphosate herbicide in transgenic plants

275

Safety evaluation of the inherent and passive safety features of the smart design

276

Safety evaluation of the phosphinothricin acetyltransferase proteins encoded by the pat and bar sequences that confer tolerance to glufosinate-ammonium herbicide in transgenic plants

277

Safety evaluation of the rocker arm of a diesel engine

278

Safety Evaluation of Topical Application of NanoLiposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial

279

Safety Evaluation of Tricalcium Phosphate/Collagen Nanocomposite Scaffold in Bone Defect in New Zealand White Rabbit Model

280

Safety evaluation of water extracts of Toona sinensis Roemor leaf

281

Safety evaluation of Whole Algalin Protein (WAP) from Chlorella protothecoides

282

Safety evaluation of wild apricot oil

283

Safety evaluation of yeast glutaminase

284

Safety evaluation of zeaxanthin concentrate (OmniXan™): Acute, subchronic toxicity and mutagenicity studies

285

Safety evaluation of α-lipoic acid (ALA)

286

Safety evaluation of β-glucanase derived from trichoderma reesei: Summary of toxicological data

287

Safety evaluation on fluoride content in black tea

288

Safety evaluation on the clinical application of Tenghuangjiangu tablet for osteoarthritis: a hospital registration study

289

Safety evaluation studies on argemone oil through dietary exposure for 90 days in rats

290

Safety evaluation to support First-In-Man investigations I: Kinetic and safety pharmacology studies

291

Safety evaluation to support first-in-man investigations II: Toxicology studies

292

Safety examination of existing concrete structures using the global resistance safety factor concept

293

Safety factor nomograms for homogeneous earth dams less than ten meters high

294

Safety Factor of Pump Vibrations on Ships Based on The Natural Frequency of Pump Vibrations According to ISO 10816-3

295

Safety factor requirements for the offshore industry

296

Safety Factors and Patterns of Bicycle Trauma in a Tertiary Level 1 Trauma Center in Boston, Massachusetts: A Retrospective Review and Survey Study

297

Safety factors considered by industrial contractors in Saudi Arabia

298

Safety factors for bridge falsework by risk management

299

Safety factors for the structural design of glass

300

Safety factors in civil aircraft design requirements

301

Safety factors in the design and use of pressure equipment

302

Safety Factors in Trees

303

Safety formats for nonlinear analysis tested on concrete beams subjected to shear forces and bending moments

304

Safety functions and component classification for the HTR-10 Original Research Article

305

Safety goals for a fusion reactor

306

Safety goals in ‘risk-informed, performance-based’ regulation

307

Safety goals in ‘risk-informed, performance-based’ regulation

308

Safety Guards for Ethereum Smart Contracts

309

Safety guidelines for exercise during pregnancy

310

Safety halls—an evaluation

311

Safety handling characteristics of high-level tritiated water

312

Safety hazard and time to recall: The role of recall strategy, product defect type, and supply chain player in the U.S. toy industry

313

Safety hazard and time to recall: The role of recall strategy, product defect type, and supply chain player in the U.S. toy industry

314

Safety I to Safety II: A Paradigm Shift or More Work as Imagined?; Comment on “False Dawns and New Horizons in Patient Safety Research and Practice”

315

Safety impact of engineering treatments on undivided rural roads

316

Safety implication for an unsaturated zone nuclear waste repository

317

Safety implications of an integrated boiling curve model for water-cooled divertor channels

318

Safety implications of CLiFF liquid metal first walls

319

Safety implications of cultural and cognitive issues in nuclear power plant operation

320

Safety implications of extending some Canadian Motor Vehicle Safety Standards to light trucks and vans

321

Safety implications of providing real-time feedback to distracted drivers

322

Safety improvement and preservation of typical sensory qualities of traditional dry fermented sausages using autochthonous starter cultures

323

Safety improvement issues for mission aborts of future space transportation systems

324

Safety improvement of lithium ion batteries by organo-fluorine compounds

325

Safety improvement of pool type FBR against loss of flow accident

326

Safety in Agricultural Extension and Development in Cross River State

327

Safety in design – Can one industry learn from another?

328

Safety in Engineering: Transactions of 3rd. BBB Symposium on Safety in Engineering, Buenos Aires, August 2000, Academia Nacional de Ingeniería, Editorial Dunken, 2000

329

Safety in Laboratories: Indian Scenario

330

Safety in Marine Operations

331

Safety in numbers: A model of managerial herd behavior

332

Safety in nursing social research

333

Safety in residential buildings-Evacuation from residential buildings without fire escape stairs

334

Safety in shipping: The human element

335

Safety in the design of offshore platforms: Integrated safety versus safety as an add-on characteristic

336

Safety in the Handling of Cryogenic Fluids : Frederick J. Edeskuty and Walter F. Stewart, Plenum Press, New York, 1996, 234 pp.

337

Safety in the histochemistry laboratory

338

Safety Incentives: Do They Reduce Injuries?

339

Safety informing design

340

SAFETY INFRASTRUCTURE FOR COUNTRIES ESTABLISHING THEIR FIRST RESEARCH REACTOR

341

Safety Instrumented System Design: Lessons Learned

342

Safety Instrumented System Design: Lessons Learned

343

Safety Investigation of Liquid-Metal-Cooled Nuclear Systems with Heat Exchanger in the Risers of Simple FlowPath Pool Design

344

Safety issues and approach to meet the safety requirements in the tokamak cooling water system of ITER

345

Safety issues associated with mobilized activation products in selected APEX designs

346

Safety issues in modern applications of robots

347

Safety issues of nuclear production of hydrogen

348

Safety issues of the liquefaction, storage and transportation of liquid hydrogen: An analysis of incidents and HAZIDS

349

Safety issues on laser megajoule facility

350

Safety knowledge of users and non-users of the lap belt on two-point motorized belt systems

351

Safety learning and imagination versus safety bureaucracy in design of the traffic sector

352

Safety level of levofloxacin following repeated oral administration in White Leg Horn layer birds

353

Safety Management Assessment System (SMAS): a process for identifying and evaluating human and organization factors in marine system operations with field test results

354

Safety Management Based on Detection of Possible Rock Bursts by AE Monitoring during Tunnel Excavation

355

Safety Management in the Jordanian Construction Industry

356

Safety Management Practices in the Bhutanese Construction Industry

357

Safety Management Strategy and Practice : R. Pybus, 1996, Butter-worth-Heinemann, ISBN 0 7506 2519 8

358

Safety Management Systems : Alan Waring, Champion&Hall, London, pp 241. ISBN 0-412-71910-X

359

Safety management systems and safety culture in aircraft maintenance organisations

360

Safety managements of the linear IFMIF/EVEDA prototype accelerator

361

Safety margin for HDR brachytherapy boost in locally advanced breast cancer

362

Safety margins confidence estimation for a passive residual heat removal system

363

Safety margins confidence estimation for a passive residual heat removal system

364

Safety margins in establishing challenges to cleaning processes are still a good idea

365

Safety margins of the W7-X plasma vessel for the static case

366

Safety Margins: Lessons from the Low Energy Endotak Trial (LEET)

367

Safety mechanisms in lithium-ion batteries

368

Safety method, Spectrophotometric Determination of Sulfamethaxazole drug in bulk and Pharmaceutical Preparations

369

Safety modeling and simulation of multi-factor coupling heavy-equipment airdrop

370

Safety monitoring of exothermic reactions using time derivatives of temperature sensors

371

Safety monitoring of herbal medicines in Nigeria: worrying state of pharmacovigilance system based on WHO core pharmacovigilance indicators

372

Safety monitoring, capital structure, and “financial responsibility”

373

Safety Motivation and Work Pressure as Predictors of Occupational Accidents in the Petrochemical Industry

374

Safety networks: fishery barometers and the outsourcing of judgement at the early Meteorological Department

375

Safety Nursing Measures for Patients Undergoing Upper Gastrointestinal Endoscopy

376

Safety objectives for next generation reactors: Proving their achievement Original Research Article

377

Safety of “Bridging” With Eptifibatide for Patients With Coronary Stents Before Cardiac and Non-Cardiac Surgery

378

Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa

379

Safety of 65 °C intravenous fluid for the treatment of hypothermia

380

Safety of a Filtrate of Fermented Garambullo Fruit: Biotransformation and Toxicity Studies

381

Safety of a New Intranasal Vaccine Against Equine Influenza: A Study of the Stability of the Ts Ca Phenotype of the Reassortant Strain in a Natural Host

382

Safety of a Trivalent Inactivated Influenza Vaccine in Health Care Workers in Kurdistan Province, Western Iran; A Longitudinal Follow-up Study

383

Safety of abciximab during percutaneous coronary intervention in patients with chronic renal insufficiency

384

Safety of abciximab in patients with chronic renal insufficiency who are undergoing percutaneous coronary interventions

385

Safety of abstract interpretations for free, via logical relations and Galois connections

386

Safety of Adenosine for Acute Pulmonary Vasoreactivity Testing in Pulmonary Hypertension

387

Safety of adjuvant aromatase inhibitor therapy

388

Safety of Aggressive Lipid Management Review Article

389

Safety of antihypertensive therapy a series of interactive panels

390

Safety of Anti-TNF-α Therapy in Patients With Psoriasis and Concomitant Hepatitis C Virus Infection

391

Safety of aprotinin (again)

392

Safety of Aqueous Extract of Tinospora cordifolia (Tc) in Healthy Volunteers: A Double Blind

393

Safety of aspartame

394

Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients

395

SAFETY OF BLOOD an‎d PLASMA DERIVATIVES: PATHOGEN REDUCING TECHNOLOGIES

396

Safety of botanical ingredients in personal care products/cosmetics

397

Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk

398

Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk

399

Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk

400

Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk

401

Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk

402

Safety of Brucella abortus RB51 vaccination of adult cows: Bacteriological evaluation of milk

403

Safety of calcium antagonists

404

Safety of Calcium Antagonists: Dissecting the Evidence

405

Safety of Cardiac Catheterization in Patients With End-Stage Liver Disease Awaiting Liver Transplantation

406

Safety of Catheter-Based Intramyocardial Autologous Bone Marrow Cells Implantation for Therapeutic Angiogenesis

407

Safety of cefepime: A new extended-spectrum parenteral cephalosporin

408

Safety of combined oral contraceptive pills

409

Safety of compressed hydrogen fuel tanks: Leakage from stationary vehicles

410

Safety of Computed Tomography in Patients With Cardiac Rhythm Management Devices: Assessment of the U.S. Food and Drug Administration Advisory in Clinical Practice

411

Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: Results of the coronary revascularization using integrilin and single bolus enoxaparin study

412

Safety of Construction in Projects in Jordan

413

Safety of Continuous Anticoagulation With Dabigatran During Implantation of Cardiac Rhythm Devices

414

Safety of Contrast Administration for Endocardial Enhancement During Stress Echocardiography Compared With Noncontrast Stress

415

Safety of Contrast in Stress Echocardiography in Stable Patients and in Patients With Suspected Acute Coronary Syndrome but Negative 12-Hour Troponin

416

Safety of controlled-onset extended-release verapamil in middle-aged and older patients with hypertension and coronary artery disease

417

Safety of coronary angioplasty to chronic total occlusions

418

Safety of coronary stenting with eptifibatide and ultra-low-dose heparin

419

Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Ablation for Atrial Fibrillation

420

Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole

421

Safety of Deep Sedation with General Anesthesia for Minor Invasive Procedures in Pediatric Hematology/Oncology Patients

422

Safety of deferring angioplasty in patients with normal coronary flow velocity reserve

423

Safety of Dental Extractions During Uninterrupted Single or Dual Antiplatelet Treatment

424

Safety of Diagnostic Balloon Occlusion in Normal Coronary Arteries

425

Safety of diagnostic coronary angiogram by radial approach in patients on chronic anticoagulation therapy with coumarin derivatives

426

Safety of Diagnostic Coronary Angiography During Uninterrupted Therapeutic Warfarin Treatment

427

Safety of dietary conjugated α-linolenic acid (CLNA) in a neonatal pig model

428

Safety of Digestive Endoscopy following Acute Coronary Syndrome: A Systematic Review

429

Safety of dipyridamole testing in patients with cerebrovascular disease

430

Safety of Dobutamine Contrast Stress Echocardiography

431

Safety of dobutamine stress real-time myocardial contrast echocardiography Original Research Article

432

Safety of Dronedarone in Routine Clinical Care

433

Safety of Drug-Eluting Stents in Patients With Left Ventricular Dysfunction Undergoing Percutaneous Coronary Intervention

434

Safety of Drug-Eluting Stents in the Coronary Artery in ST-Elevation Myocardial Infarction at a Single High-Volume Medical Center

435

Safety of drug-eluting stents: demystifying network meta-analysis

436

Safety of dynamic positioning operations on mobile offshore drilling units

437

Safety of dynamic positioning operations on mobile offshore drilling units

438

Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction

439

SAFETY OF EARLY ORAL FEEDING AFTER TRANSHIATAL ESOPHAGECTOMY: PRELIMINARY REPORT OF A PROSPECTIVE TRIAL

440

SAFETY OF EARLY VERSUS DELAYED ENTERAL FEEDING FOLLOWING ILEOSTOMY CLOSURE: RANDOMIZED CONTROLLED TRIAL

441

Safety of elective—including “high risk”—percutaneous coronary interventions without on-site cardiac surgery

442

Safety of electronic circuits integrated into personal protective equipment (PPE)

443

Safety of enoxaparin versus unfractioned heparin in patients undergoing percutaneous coronary intervention using drug eluting stents: A pilot study

444

Safety of erythritol in the diet

445

Safety of Exercise Stress Testing in Patients With Abnormal Concentrations of Serum Potassium

446

Safety of Expedited Anticoagulation in Patients Undergoing Transesophageal Echocardiographic-guided Cardioversion

447

Safety of fast neutron reactor power units under operation and design in Russia Original Research Article

448

Safety of femoral closure devices after percutaneous coronary interventions in the era of glycoprotein IIb/IIIa platelet blockade

449

Safety of first-trimester exposure to topical tretinoin: prospective cohort study

450

Safety of fusion magnets: Model experiments to high current arcs at ITER busbars and feeder lines

451

Safety of fusion magnets: Pressure impact on arcing in model experiments to high-current arcs propagating along the busbars of large fusion magnet coils

452

Safety of Genetically Engineered Foods. Approaches to Assessing Unintended Health Effects

453

Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects, Institute of Medicine and National Research Council of the National Academies. The National Academies Press, Washington, USA (2004), ISBN: 0-309-09209-4

454

Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon’s perspective

455

Safety of gold in stapes surgery

456

Safety of HealthcareWorkers During the Airway Management in Adult and Pediatric Patients with COVID-19

457

Safety of heart rate–lowering calcium antagonists:Lessons from controlled trials, ,

458

Safety of herbal medicine in treatment of weight loss

459

Safety of high doses of Propionibacterium freudenreichii ET-3 culture in healthy adult subjects

460

Safety of High-Dose Atorvastatin Therapy

461

Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature

462

Safety of Hypericum extract in mildly to moderately depressed outpatients: A review based on data from three randomized, placebo-controlled trials

463

Safety of Imaging Exploding Bullets With Ultrasound, ,

464

Safety of immunization and adverse events following vaccination against hepatitis B

465

Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory

466

Safety of Improved Milbond-TX® when fed in broiler diets at greater than recommended levels

467

Safety of Inactivated Influenza Vaccine in Patients with Egg Allergy in Kurdistan Province, Iran

468

Safety of influenza vaccination during pregnancy

469

Safety of influenza vaccination during pregnancy

470

Safety of influenza vaccines in children

471

Safety of injectable opioid maintenance treatment for heroin dependence

472

Safety of Inoue balloon mitral commissurotomy in patients with left atrial appendage thrombi

473

Safety of insulin glargine

474

Safety of insulin tolerance test for the assessment of growth hormone deficiency in children

475

Safety of intra-amniotic digoxin administration before late second-trimester abortion by dilation and evacuation,

476

Safety of intracoronary Doppler flow measurement

477

Safety of Intracoronary Ultrasound Imaging in Patients With Acute Myocardial Infarction

478

Safety of intramedullary autologous peripheral nerve grafts for post-rehabilitated complete motor spinal cord injuries: a phase I study.

479

Safety of intravenous immunoglobulin (IVIG) therapy

480

Safety of Intravenous Thrombolysis for Stroke in a Patient With Multiple Intracranial Neoplasm

481

Safety of intravenous use of ketorolac in infants following cardiothoracic surgery

482

Safety of Intravitreal Injection of Stivant, a Biosimilar to Bevacizumab, in Rabbit Eyes

483

Safety of Intravitreal Zoledronic Acid, an Anti-angiogenic Bisphosphonate, in a Rat Model

484

Safety of irbesartan in the treatment of mild to moderate systemic hypertension

485

Safety of irradiated foods (2nd edition): J. F. Diehl. Marcel Dekker Inc., 1995. ISBN 0 82479 344 7. 464 pp. $175

486

Safety of irradiated foods (2nd edition): J. F. Diehl. Marcel Dekker Inc., 1995. ISBN 0 82479 344 7. 464 pp. $175

487

Safety of Ivabradine in Patients With Coronary Artery Disease and Left Ventricular Systolic Dysfunction (from the BEAUTIFUL Holter Substudy)

488

Safety of Ketoprofen in Cow calves following repeated intravenous administration

489

Safety of labor epidural anesthesia for women with severe hypertensive disease, , ,

490

Safety of lacosamide in children with refractory partial epilepsy

491

Safety of left innominate vein division during aortic arch surgery

492

Safety of left ventriculography in aortic stenosis

493

Safety of lithium batteries in transportation

494

Safety of long railway tunnels

495

Safety of long railway tunnels

496

Safety of Lovastatin/Extended Release Niacin Compared With Lovastatin Alone, Atorvastatin Alone, Pravastatin Alone, and Simvastatin Alone (from the United States Food and Drug Administration Adverse Event Reporting System)

497

Safety of low hematocrits during cardiopulmonary bypass

498

Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)

499

Safety of Lower Activated Clotting Times During Atrial Fibrillation Ablation Using Open Irrigated Tip Catheters and a Single Transseptal Puncture

500

Safety of lumbar drains in thoracic aortic operations performed with extracorporeal circulation

501

Safety of Magnetic Resonance Imaging One to Three Days After Bare Metal and Drug-Eluting Stent Implantation

502

Safety of maritime transportation

503

Safety of medically supervised exercise in a cardiac rehabilitation center

504

Safety of Methotrexate in Chronic Urticaria Unresponsive to Omalizumab

505

Safety of metronidazole in pregnancy: A meta-analysis

506

Safety of Microorganisms Intended for Pest and Plant Disease Control: A Framework for Scientific Evaluation

507

Safety of Minimally Invasive Mitral Valve Surgery Without Aortic Cross-Clamp

508

Safety of minocycline for acne

509

Safety of modern oral contraceptives

510

Safety of Moxifloxacin following repeated intramuscular administration in Wistar rats

511

Safety of Naloxone in Opioid-Naive Methadone Intoxicated Patients; a Case Series Study

512

Safety of nicotine in smokers with hypertension

513

Safety of oral immunisation with recombinant urease in patients with Helicobacter pylori infection

514

Safety of oral itraconazole in the treatment of seborrheic dermatitis

515

Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm:: A prospective parallel placebo-controlled multicentre study

516

Safety of Oral Propafenone in the Treatment of Arrhythmias in Infants and Children (European Retrospective Multicenter Study)

517

Safety of outpatient dental anaesthesia for children

518

Safety of parenteral dexamethasone vs. oral prednisolone in the treatment of pemphigus vulgaris

519

Safety of passing longer combination vehicles on two-lane highways

520

Safety of patent ductus arteriosus closure in premature infants without tube thoracostomy

521

Safety of patient meals in 2 hospitals in Alexandria, Egypt before and after training of food handlers

522

Safety of Percutaneous Transfemoral Coronary and Peripheral Procedures Via Aortofemoral Synthetic Vascular Grafts

523

Safety of performing dobutamine stress echocardiography in patients with abdominal aortic aneurysm ≥4 cm in diameter

524

Safety of perioperative statin use in high-risk patients undergoing major vascular surgery

525

Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study

526

Safety of power transmission line structures under wind and ice storms

527

Safety of Prestressed Concrete Bridges to Fatigue: Application to Serviceability Limit State of Decompression

528

Safety of primary percutaneous coronary intervention with and without (selective) thrombus aspiration

529

Safety of probiotics in patients receiving enteral or parenteral nutrition: a systematic review of trials and case reports

530

Safety of prolonging peripheral cannula and IV tubing use from 72 hours to 96 hours, ,

531

Safety of psychotropic medications in liver disease

532

Safety of purified decolorized (low anthraquinone) whole leaf Aloe vera (L) Burm. f. juice in a 3-month drinking water toxicity study in F344 rats

533

Safety of PVAP and PVAP-T including a 90-day dietary toxicity study in rats and genotoxicity tests with polyvinyl acetate phthalate (PVAP)

534

Safety of Radiofrequency Ablation of Thoracic T2 and T3 Sympathectomy in Palmar Hyperhidrosis: A Case Report

535

Safety of Raloxifene in Hemodialysis Patients

536

Safety of raltitrexed

537

Safety of raltitrexed

538

Safety of raw meat and shellfish in Vietnam: An analysis of Escherichia coli isolations for antibiotic resistance and virulence genes

539

Safety of recommended doses of paracetamol

540

Safety of Regadenoson in Patients with End-Stage Renal Disease

541

Safety of Reloading Prasugrel in Addition to Clopidogrel Loading in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention

542

Safety of remote aortic valve replacement after prior coronary artery bypass grafting

543

Safety of repeat aprotinin administration for LVAD recipients undergoing cardiac transplantation

544

Safety of RNA-Dependent RNA Polymerase Inhibitors, Molnupiravir and VV116, for Oral Treatment of COVID-19: A Meta-Analysis

545

Safety of rosuvastatin

546

Safety of rTMS to non-motor cortical areas in healthy participants and patients

547

Safety of Same-Day Discharge After Percutaneous Coronary Intervention: What Is the Level of Evidence?

548

Safety of same-day–discharge radial percutaneous coronary intervention: a retrospective study

549

Safety of Selective Serotonin Reuptake Inhibitor in Adults Undergoing Coronary Artery Bypass Grafting

550

Safety of shellfish and epidemiological pattern of enterically transmitted diseases in Italy

551

Safety of short-term cyclosporin in atopic dermatitis

552

Safety of Short-Term Use of Dabigatran or Rivaroxaban for Direct-Current Cardioversion in Patients With Atrial Fibrillation and Atrial Flutter

553

Safety of sildenafil citrate in the management of hypertensive disorders of pregnancy

554

SAFETY OF SINGLE LAYER CONTINUOUS EXTRA MUCOSAL GUT ANASTOMOSIS IN EMERGENCY

555

Safety of Sirolimus-Eluting Stenting and Its Effect on Restenosis in Patients With Unstable Angina Pectoris (a SIRIUS Substudy)

556

Safety of Skeletal Traction through the Distal Femur, Proximal Tibia, and Calcaneus

557

Safety of Slow Pathway Ablation in Patients With Atrioventricular Node Reentrant Tachycardia and a Long Fast Pathway Effective Refractory Period

558

Safety of SodiumGlucose CoTransporter 2 Inhibitors during Ramadan Fasting: Evidence, Perceptions and Guidelines

559

Safety of St Johnʹs wort (Hypericum perforatum)

560

Safety of St Johnʹs wort (Hypericum perforatum)

561

Safety of St Johnʹs wort (Hypericum perforatum)

562

Safety of Stress Echocardiography (from the International Stress Echo Complication Registry)

563

Safety of Stress Echocardiography: The Advantages of Transesophageal Atrial Pacing

564

Safety of stress testing in patients with hypertrophic cardiomyopathy

565

Safety of subxyphoid pericardial access using a blunt-tip needle

566

Safety of succinylcholine in myasthenia gravis

567

Safety of surfaces and equipment for children in playgrounds

568

Safety of surgical personnel: a global concern

569

Safety of Surgical Tracheostomy during Extracorporeal Membrane Oxygenation

570

Safety of tamoxifen

571

Safety of Targeted Perioperative Mupirocin Treatment for Preventing Infections After Cardiac Surgery

572

Safety of the blood supply: role of pathogen reduction

573

Safety of the Excimer Laser in LASIK and PRK for Patients with Implantable Cardiac Devices: Our Clinical Experience in the Past Two Decades

574

Safety of the magnetic field generated by a neuronal magnetic stimulator: evaluation of possible mutagenic effects

575

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

576

Safety of the underground disposal of carbon dioxide

577

Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-Trial

578

Safety of Thoracic Aortic Surgery in the Present Era

579

Safety of thrombolytic agents in acute ischemic stroke: Analysis of randomized controlled trials

580

Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial

581

Safety of topical dinitrochlorobenzene

582

Safety of Transvenous Cardiac Resynchronization System Implantation in Patients With Chronic Heart Failure: Combined Results of Over 2,000 Patients From a Multicenter Study Program Original Research Article

583

Safety of trivalent chromium complexes: No evidence for DNA damage in human HaCaT keratinocytes

584

Safety of tumour necrosis factor and interleukin-1 blocking agents in rheumatic diseases

585

SAFETY OF ULTRASONIC DISSECTION VERSUS CONVENTIONAL ELECTROCAUTERY DISSECTION DURING LAPROSCOPIC CHOLECYSTECTOMY IN TERMS OF GALL BLADDER PERFORATION

586

Safety of Ultrasound Contrast Agents in Patients With Known or Suspected Cardiac Shunts

587

Safety of Ultrasound Contrast Agents in Stress Echocardiography

588

Safety of umbilical cord blood-derived mesenchymal stem cells (MSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by MSCs

589

Safety of Vaginal Misoprostol for the Termination of Second Trimester Miscarriage in Women with Previous Uterine Scar in Iraq

590

Safety of vegetables and the use of pesticides by farmers in China: Evidence from Zhejiang province

591

Safety oriented analysis of cold helium–air mixture formation and stratification Original Research Article

592

Safety Outcomes of Intrastromal Injection of Sodium Hypochlorite in the Normal Rabbit Cornea

593

Safety Performance in Ammonia Plants: Survey VI

594

Safety Performance in Ammonia Plants: Survey VI

595

Safety Performance of Subcontractors in the Palestinian Construction Industry

596

Safety pictograms: are they getting the message across?

597

Safety Planning Intervention: A Brief Intervention to Mitigate Suicide Risk Original Research Article

598

Safety practices and depression among farm residents

599

Safety Predictors in Performance of Activities of Daily Living in Patients with Parkinson’s Disease

600

Safety preserving control synthesis for sampled data systems

601

Safety Procedure for Biosafety and Controlling a Communicable Disease: Streptococcus Suis

602

Safety product evaluation: Six years of experience

603

Safety profile and complications of autologous limbal conjunctival transplantation for primary pterygium

604

Safety profile and gender specific differences of a methanol extract of Eriosema laurentii (Leguminosae) in acute and subchronic (28 days) oral toxicity studies in Wistar rats

605

Safety profile assessment and efficacy of chemically characterized Cinnamomum glaucescens essential oil against storage fungi, insect, aflatoxin secretion and as antioxidant

606

Safety profile of a food dextrin: Acute oral, 90-day rat feeding and mutagenicity studies

607

Safety profile of atorvastatin-treated patients with low LDL-cholesterol levels

608

Safety profile of bupropion for chronic obstructive pulmonary disease

609

Safety profile of bupropion for chronic obstructive pulmonary disease

610

Safety profile of bupropion for chronic obstructive pulmonary disease

611

Safety profile of bupropion for chronic obstructive pulmonary disease

612

Safety profile of conjugated linoleic acid in a 12-month trial in obese humans

613

Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: Impact on bone metabolism, bone density, and adrenal function

614

Safety Profile of Levonorgestrel: A Disproportionality Analysis of Food and Drug Administration Adverse Event Reporting System (FAERS) Database

615

Safety Profile of Levonorgestrel: A Disproportionality Analysis of Food and Drug Administration Adverse Event Reporting System (Faers) Database

616

Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators

617

Safety profile of low-dose aspirin

618

Safety profile of parenteral ketamine and lignocaine infiltration in pediatric operations

619

Safety profile of perindopril

620

Safety profile of RNAi nanomedicines

621

Safety Profile of Subjects Treated to Very Low Low-Density Lipoprotein Cholesterol Levels (<30 mg/dl) With Rosuvastatin 20 mg Daily (from JUPITER)

622

Safety profile of transdermal testosterone therapy in women

623

Safety Profile of Using Ciprofloxacin in Paediatrics: A Systematic Review and Meta-Analysis

624

Safety profiles of leading nonsteroidal anti-inflammatory drugs

625

Safety Program Guidelines for Public School Facility Construction and Operations

626

Safety Property Verification Using Sequential SAT and Bounded Model Checking

627

Safety Recommendations — The engine that drives change

628

Safety requirements for the design of large containers for decommissioning waste

629

Safety risk analysis based on a geotechnical instrumentation data warehouse in metro tunnel project

630

Safety risk assessment and management—the ESA approach

631

Safety Risk Assessment in Educational Environments: A Case Study in Qom University of Medical Sciences

632

Safety Risk Assessment in Medical and Paramedical Education Laboratories

633

Safety Risk Assessment in the Tile Industry with a New Approach

634

Safety Risk Assessment; Using Fuzzy Failure Mode and Effect Analysis and Fault Tree Analysis

635

Safety risk identification system for metro construction on the basis of construction drawings

636

Safety Risk Management in Production Process: A case study in the automotive supplier industry

637

Safety Risk Management of Automaker Industries Using Combination of Fuzzy FMEA and Vikor (Case Study: Pre-Paint Hall of Iran-Khodro Company)

638

Safety rules and regulations on mine sites – The problem and a solution

639

Safety rules: procedural freedom or action constraint?

640

Safety scenario and integrated thermofluid test

641

Safety Signs Perception and Adoption with the ISO and ANSI Standards

642

Safety standards for human exposure to radio frequency radiation and their biological rationale

643

Safety Status of Schools in Shiraz and its Related Factors

644

Safety stocks in multi-stage inventory systems under different service measures

645

SAFETY STRATEGY ALLOCATION SIMULATOR FOR ACCIDENT REDUCTION AND COST SAVINGS IN SAFETY MANAGEMENT SYSTEM

646

Safety strategy for the first deployment of a hydrogen-based green public building in France

647

Safety studies conducted on a proprietary high-purity aloe vera inner leaf fillet preparation, Qmatrix®

648

Safety studies conducted on high-purity trans-resveratrol in experimental animals

649

Safety studies of a hydrogen refuelling station: Determination of the occurrence frequency of the accidental scenarios

650

Safety studies of a novel starch, pullulan: Chronic toxicity in rats and bacterial mutagenicity

651

Safety studies of l-alanyl-l-glutamine (l-AG)

652

Safety studies of LP20 powder produced from heat-killed Lactobacillus plantarum L-137

653

Safety studies of pseudo-ceramide SLE66. Part 2: Metabolism, cytotoxicity and genotoxicity

654

Safety studies of pseudo-ceramide SLE66. Part 3: Effects on embryo/fetal development in rats

655

Safety studies of pseudo-ceramide SLE66: Acute and short-term toxicity

656

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 1: Genotoxicity

657

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: Dermal, acute and short-term toxicity studies

658

Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats

659

Safety studies on high-pressure hydrogen vehicle refuelling stations: Releases into a simulated high-pressure dispensing area

660

Safety studies on Korean fusion DEMO plant using integrated safety assessment methodology

661

Safety studies on products from whole coffee fruit

662

Safety studies related to the spent fuel storage of the Romanian VVR-S reactor

663

Safety studies: Review of loss of plasma control transients in ITER with AINA 3.0 code

664

Safety study of a hydrogen leak in a fuel cell vehicle using computational fluid dynamics

665

Safety study of high-frequency transcranial magnetic stimulation in patients with chronic stroke

666

Safety study of the coupling of a VHTR with a hydrogen production plant

667

Safety system consideration of a supercritical-water cooled fast reactor with simplified PSA

668

Safety systems for the ESES 2002 wind pump

669

Safety target of very large floating structure used as a floating airport

670

Safety teams: Government and business organizations want them and use them, but are they legal?

671

Safety testing of domestic refrigerators using flammable refrigerants

672

Safety testing of GM-rice expressing PHA-E lectin using a new animal test design

673

Safety testing of lithium ion batteries for navy devices

674

Safety testing of tannase from Aspergillus oryzae

675

Safety Testing of Tebufenozide, a New Molt-Inducing Insecticide, for Effects on Nontarget Forest Soil Invertebrates

676

Safety values and safe practices among college students

677

Safety valves for photosynthesis

678

Safety verification for the ECCS driven by the electrically 4 trains during LBLOCA reflood phase using ATLAS

679

Safety Verification of Rate-Monotonic Least-Splitting Real-Time Scheduler on Multiprocessor System

680

Safety Verification of Semi-Algebraic Dynamical Systems via Inductive Invariant

681

Safety warnings and first aid instructions on consumer and pharmaceutical products in Nigeria: has there been an improvement?

682

Safety with access scaffolds: Development of a prototype decision aid based on accident analysis

683

Safety Zone Problem

684

Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project

685

Safety, Acceptance, and Hesitancy of COVID-19 Vaccines Among High-risk Sub-populations: A Narrative Review

686

Safety, domain independence and generalized quantification

687

Safety, domain independence and translation of complex value database queries

688

Safety, economic incentives and insurance in the Norwegian petroleum industry

689

Safety, economic incentives and insurance in the Norwegian petroleum industry

690

Safety, effectiveness and costs of different models of organising care for critically ill patients: Literature review

691

Safety, effectiveness and economic aspects of maggot debridement therapy for wound healing

692

Safety, effectiveness and economic evaluation of intra-operative radiation therapy: a systematic review

693

Safety, Effectiveness, and Outcomes of Cardiac Catheterization in Nonagenarians

694

Safety, effectiveness, and outcomes of concomitant use of highly active antiretroviral therapy with drugs for tuberculosis in resource-poor settings

695

Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion, , ,

696

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimerʹs disease: a phase IIa, double-blind, randomised, placebo-controlled trial

697

Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma

698

Safety, Efficacy, and Tolerability of Sofosbuvir and Ribavirin in Management of Recurrent Hepatitis C Virus Genotype 4 After Living Donor Liver Transplant in Egypt: What Have We Learned so far?

699

Safety, Efficacy, Predictability and Stability Indices of Photorefractive Keratectomy for Correction of Myopic Astigmatism with Plano-Scan and Tissue-Saving Algorithms

700

Safety, Feasibility of Intravenous and Intrathecal Injection of Autologous Bone Marrow Derived Mesenchymal Stromal Cells in Patients with Amyotrophic Lateral Sclerosis: An Open Label Phase I Clinical Trial

701

Safety, feasibility, and diagnostic accuracy of accelerated high-dose dipyridamole stress echocardiography

702

Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting

703

Safety, Health and Environment in Small Process Plants—Results from a European Survey

704

Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae 0139 vaccine prototype

705

SAFETY, IMMUNOGENICITY, AND PROTECTIVE EFFICACY OF NYVAC-JEV AND ALVAC-JEV RECOMBINANT JAPANESE ENCEPHALITIS VACCINES IN RHESUS MONKEYS

706

Safety, Long-Term Results, and Predictors of Recurrence After Complete Endocardial Ventricular Tachycardia Substrate Ablation in Patients With Previous Myocardial Infarction

707

Safety, reliability and security of industrial computer systems

708

Safety, reliability and security of industrial computer systems

709

Safety, reliability and security of industrial computer systems

710

Safety, reliability and security of industrial computer systems

711

Safety, suspicions, scrutiny, conflicts and lessons: balancing risks and benefit of Vioxx

712

Safety, Tolerability and Efficacy of Neoadjuvant Chemoirradiation for Operable Esophageal Carcinoma, a Case Series Study

713

Safety, Tolerability, and Efficacy of a Glucose-Insulin-Potassium-Magnesium-Carnitine Solution in Acute Myocardial Infarction

714

Safety, Tolerability, and Efficacy of Acupuncture in Management of Neonatal Abstinence Syndrome (NAS): A Systematic Review

715

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Primary Results of the DISPERSE-2 Tri

716

Safety, Tolerance, and Efficacy of Adenosine as an Additive to Blood Cardioplegia in Humans During Coronary Artery Bypass Surgery

717

Safetyanalysisofanaccelerator-driventestfacilityOriginalResearchArticle

718

Safetyanalysisofmultiple-failureofpassivesafetysystemsinSBWR-1200SBLOCAOriginalResearchArticle

719

SafetyanalysisofUlchinNuclearPowerPlantagainstNihonkai-ChubuEarthquakeTsunamiOriginalResearchArticle

720

SafetyassessmentofalithiumtargetOriginalResearchArticle

721

Safety-barrier diagrams as a safety management tool

722

Safety-barrier diagrams as a safety management tool

723

Safety-barrier diagrams as a tool for modelling safety of hydrogen applications

724

Safety-belt effectiveness: The influence of crash severity and selective recruitment

725

Safety-culture in a Norwegian shipping company

726

SafetydemonstrationtestsusinghightemperatureengineeringtestreactorOriginalResearchArticle

727

Safety-design criteria of sliding systems for preventing friction-induced vibration

728

Safetydesignmaps:anearlyevaluationofsafetytosupportreactordesignOriginalResearchArticle

729

SafetydesignOriginalResearchArticle

730

SafetyevaluationofrehabilitationofdelaminatedcontainmentdomeOriginalResearchArticle

731

SafetyevaluationoftheHTTROriginalResearchArticle

732

Safetyevaluationonthedepressurizationaccidentinthegasturbinehightemperaturereactor(GTHTR300)OriginalResearchArticle

733

Safety-first analysis and stable paretian approach to portfolio choice theory

734

Safety-first and extreme value bilateral U.S.–Mexican portfolio optimization around the peso crisis and NAFTA in 1994

735

Safety-first portfolio optimization for US\Investors\In emerging global, Asian and Latin American market

736

Safety-level communication in railway interlockings

737

Safety-limit curves for earthing system designs: appraisal of standard recommendations

738

SafetymanagementinNPPsusinganevolutionaryalgorithmtechniqueOriginalResearchArticle

739

Safety-net role of tree roots: evidence from a pecan (Carya illinoensis K. Koch)–cotton (Gossypium hirsutum L.) alley cropping system in the southern United States

740

SafetyNet: A language-based approach to programmable networks

741

Safety-related decision making at a nuclear power plant Original Research Article

742

Safety-related equipment prioritization for reliability centered maintenance purposes based on a plant specific level 1 PSA

743

Safety-related plasma events for ITER-FEAT

744

Safety-related studies on hydrogen production in high-pressure electrolysers

745

Safety-relevant mode confusions—modelling and reducing them

746

Safety-relevant mode confusions—modelling and reducing them

747

Safeware: System safety and computers. A guide to preventing accidents and losses caused by technology : by Nancy G. LEVESON. Addison-Wesley; Reading, MA, USA; 1995; 680 pp.; $49.43; ISBN: 0-201-11972-2

748

Safe-water shortages, gender perspectives, and related challenges in developing countries: The case of Uganda Original Research Article

749

Safflower (Carthamus tinctorius L.) as a novel pasture species for dairy sheep in the Mediterranean conditions of Sardinia and Israel

750

Safflower model for simulation of growth and yield under various irrigation strategies, planting methods and nitrogen fertilization

751

SAFFLOWER PRODUCTIVITY DEPENDING ON SEED TREATMENT BY AKM PLANT GROWTH REGULATOR AND LEVEL OF MINERAL NUTRITION

752

Safflower seeds in corn silage and alfalfa hay based early lactation diets: A practice within an optimum forage choice

753

SAFFLOWER YIELD RESPONSE TO IRRIGATION AND GAMMA IRRADIATION

754

Saffman–Taylor fingering in nanosecond pulse laser ablating bulk metallic glass in water

755

Saffman-Taylor fingers with anisotropic surface tension

756

Saffron (Crocus sativus L.) increases glucose uptake and insulin sensitivity in muscle cells via multipathway mechanisms

757

Saffron (Crocus sativus L.) Supplements Modulate Circulating MicroRNA (miR-21) in Atherosclerosis Patients; A Randomized, Double-Blind, Placebo-Controlled Trial

758

Saffron (Crocus Sativus L.), Combined with Endurance Exercise, Synergistically Enhances BDNF, Serotonin, and NT-3 in Wistar Rats

759

Saffron (Crocus sativus) petal as a new pharmacological target: a review

760

Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial

761

Saffron allergy

762

Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease

763

Saffron and its active ingredients against human disorders: A literature review on existing clinical evidence

764

Saffron Aqueous Extract Inhibits the Chemically-induced Gastric Cancer Progression in the Wistar Albino Rat

765

Saffron as an antidote or a protective agent against natural or chemical toxicities

766

Saffron as an antidote or a protective agent against natural or chemical toxicities

767

Saffron Crocus sativus L. tolerance to some herbicides

768

Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide

769

Saffron Flower and Stigma Yield Changes in Response to Application of Different Levels of super Absorbent Polymer

770

Saffron future contract yield prediction using a modified quadratic model

771

Saffron improved depression and reduced homocysteine level in patients with major depression: A Randomized, double-blind study

772

Saffron Improves Epididymal Sperm Parameters in Rats Exposed to Cadmium

773

Saffron Induced Relaxation in Isolated Rat Aorta via Endothelium Dependent and Independent Mechanisms

774

Saffron Irrigation Regime

775

Saffron nephroprotective effects against medications and toxins: A review of preclinical data

776

Saffron offers hepatoprotection via up-regulation of hepatic farnesoid-X-activated receptors in a rat model of acetaminophen-induced hepatotoxicity

777

Saffron Petals, a By-Product for Dyeing of Wool Fibers

778

Saffron Protection against Bleomycin-Induced Pulmonary Fibrosis in Rats

779

Saffron Reduced Toxic Effects of its Constituent, Safranal, in Acute and Subacute Toxicities in Rats

780

Saffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial

781

Saffron suppresses oxidative stress in DMBA-induced skin carcinoma: A histopathological study

782

Saffron vegetative growth as affected by transplanting and direct corm planting under field conditions

783

Saffron: A Herbal Medicine of Third Millennium

784

Saffron’omics’: The challenges of integrating omic technologies

785

Safic-Alcan buys Hubronʹs business in Czech Republic

786

Safire—a neural network based instrument for in-situ airborne fibre recognition

787

SAFOD Brittle Microstructure and Mechanics Knowledge Base (BM2KB)

788

Safranal Ameliorates Ischemic/Reperfusion Injury Induced by Testicular Torsion in Rat

789

Safranal as a safe compound to mice immune system

790

Safranal, a Crocus sativus L constituent suppresses the growth of K-562 cells of chronic myelogenous leukemia. In silico and in vitro study

791

Safranal: From an Aromatic Natural Product to a Rewarding Pharmacological Agent

792

Safranal-loaded solid lipid nanoparticles: evaluation of sunscreen and moisturizing potential for topical applications

793

Safrole oxide induces apoptosis by activating caspase-3, -8, and -9 in A549 human lung cancer cells

794

Safrole oxide induces apoptosis by up-regulating Fas and FasL instead of integrin β4 in A549 human lung cancer cells Original Research Article

795

Safrole oxide is a useful tool for investigating the effect of apoptosis in vascular endothelial cells on neural stem cell survival and differentiation in vitro

796

Safrole-induced Oxidative Damage in the Liver of Sprague–Dawley Rats

797

Saft lithium-ion energy and power storage technology

798

SAFT model for upstream asphaltene applications

799

SAFT prediction of vapour-liquid equilibria of mixtures containing carbon dioxide and aqueous monoethanolamine or diethanolamine

800

SAG attenuates apoptotic cell death caused by simulated ischaemia/reoxygenation in rat cardiomyocytes

801

SAG MILL POWER DRAW SIMULATION USING VARIANCE PROPAGATION APPROACH.

802

Sag mitigation by an electronic tapchanger: specifications and comparisons with other custom power tools

803

Saga of Discrimination of Girl Child in India

804

Saga of effciency degradation at high injection in InGaN light emitting diodes

805

SAGA: A novel signal alignment method based on genetic algorithm

806

Sagaria cilentana gen. et sp. nov.-A New Angiosperm Fructification from the Middle Albian of Southern Italy

807

Sagarmatha Park (Mt Everest) porter survey and analysis

808

SAGBI and SAGBI-Gröbner Bases over Principal Ideal Domains

809

SAGBI Bases Under Composition

810

SAGD laboratory experimental and numerical simulation studies: A review of current status and future issues

811

SAGD well orientation in point bar oil sand deposit affects performance

812

SAGE algorithms for multipath detection and parameter estimation in asynchronous CDMA systems

813

SAGE analysis highlights the importance of p53csv, ddx5, mapkapk2 and ranbp2 to multiple myeloma tumorigenesis

814

SAGE CULTIVATION POSSIBILITIES IN “MALESIA E MADHE”: ITS DEVELOPMENTS AND PERSPECTIVES

815

SAGE MD: molecular-dynamic software package to study properties of materials with different models for interatomic interactions

816

SAGE mRNA expression in advanced-stage lung cancers

817

Sage publications/SRM database of social research methodology on CD-ROM : Scolari software, Sage publications, 1995. $750 (stand alone version), $1125 (network version) (ISBN 07619-0084-5)

818

Sage, guide or ghost? The effect of instructor intervention on student participation in online discussion forums

819

Sagging and collapse sinkholes over hypogenic hydrothermal karst in a carbonate terrain

820

Sagitol C, a new cytotoxic pyridoacridine alkaloid from the sponge Oceanapia sp.

821

Sagittal Alignment Following the Kyphoplasty of Acute Versus Chronic Osteoporotic Vertebral Compression Fracture

822

Sagittal curvature of total knee replacements predicts in vivo kinematics

823

Sagittal plane biomechanics cannot injure the ACL during sidestep cutting

824

Sagittal plane lower extremity kinematics in children with Hereditary Spastic Paraplegia

825

Sagittal plane moment arms of the female lumbar region rectus abdominis in an upright neutral torso posture

826

Sagittal plane motion in the human lumbar spine: Comparison of the in vitro quasistatic neutral zone and dynamic motion parameters

827

Sagittal plane motion of the lumbar spine during normal gait

828

Sagittal plane segmental motion of the cervical spine. A new precision measurement protocol and normal motion data of healthy adults

829

Sagittal ramus split osteotomy: literature review and suggested modification of technique

830

Sagittal range of motion of the thoracic spine using standing digital radiography: A throughout comparison with non-radiographic data reviewed from the literature

831

Sagittal sinus thrombosis after closed head injury

832

Sagittal sinus thrombosis associated with transient free protein S deficiency after -asparaginase treatment: case report and review of the literature

833

Sagittal Spinal Mobility and Back Extensor Muscle Function in Older Females with Age-Related Hyperkyphosis

834

Sagittal spine and lower limb movement during sit-to-stand in healthy young subjects

835

Sagittal Spinopelvic Alignment in Asymptomatic Iranian Adults Aged 18 to 40 Years

836

Sagittal split osteotomy of a vascularised iliac crest free flap to correct residual asymmetry and malocclusion in the reconstructed mandible

837

Sagittal vein thrombosis caused by central vein catheter.

838

SAĞLIK FİNANSMANINI DEĞERLENDİRME ÖLÇÜTLERİ

839

Sağlık Hizmetleri Meslek Yüksekokullarında Verilen Eğitimle İlgili Sorunlar, Çözüm Önerileri, Uludağ Üniversitesi Sağlık Hizmetleri Meslek Yüksekokulundaki Durum ve Yürütülen Çalışmalar

840

Sağlık Hizmetleri Meslek Yüksekokulu Öğrencilerinde Ayak Ark Patolojileri İle Ayakkabı Tercihleri Arasındaki İlişkinin Değerlendirilmesi

841

Sağlık teknolojisinde yaşam kalitesi analizlerinin kullanımı

842

Sagliker Syndrome in a Patient with Secondary Hyperparathyroidism and Chronic Renal Insufficiency: A Case Report

843

Sagnac-based rotation sensing with superfluid helium quantum interference devices

844

Sago pith meal based diets in sheep containing different sources of nitrogen: Feed preparation, growth performance, digestibility and carcass quality

845

Sago starch and composition of associated components in palms of different growth stages

846

Sago starch as a biomass source: Raw sago starch hydrolysis by commercial enzymes

847

Sago starch as binder and pore-forming agent for the fabrication of porcelain foam

848

Saguaro recruitment over their American range: a separation and comparison of summer temperature and rainfall

849

Şah İsmail s Wife

850

Sahara dust, ocean spray, volcanoes, biomass burning: pathways of nutrients into Andean rainforests

851

Saharan aeolian input and effective humidity variations over western Europe during the Holocene from a high altitude record

852

Saharan dust and phosphatic fidelity: A three-dimensional biogeochemical model of Trichodesmium as a nutrient source for red tides on the West Florida Shelf

853

Saharan dust contributions to PM10 and TSP levels in Southern and Eastern Spain

854

Saharan dust distributions near the Gulf of Guinea

855

Saharan dust episodes in Hungarian aerosol: elemental signatures and transport trajectories

856

Saharan dust flux and deposition rate near the Gulf of Guinea

857

Saharan dust impact in central Italy: An overview on three years elemental data records

858

Saharan dust in nighttime thermal imagery: Detection and reduction of related biases in retrieved sea surface temperature

859

Saharan dust inputs to the western Mediterranean Sea: depositional patterns, geochemistry and sedimentological implications

860

Saharan dust occurrence at a mid tropospheric site in Tenerife

861

Saharan dust outbreak over southeastern Spain as detected by sun photometer

862

Saharan dust particle properties over the central Mediterranean

863

Saharan dust storms over the Canary Islands during winter 1998 as depicted from the advanced very high-resolution radiometer

864

Saharan dust storms: nature and consequences

865

Saharian dust from ancient times until the present. A note on methods of study

866

Sahel pastoralists: opportunism, struggle, conflict and negotiation. A case study from eastern Niger

867

Sahel, savana, riverine and urban malaria in West Africa: Similar control policies with different outcomes

868

Sahelian rangeland response to changes in rainfall over two decades in the Gourma region, Mali

869

Sahîh-i Buhârî’nin Eksiksiz En Eski Nüshasının Şeyh Alî el-Bistâmî (Musannifek) Eliyle İstanbul’a Getirildiğine Dâir Bazı Şüpheler

870

Sahiwal cattle in Pakistan: genetic and environmental causes of variation in body weight and reproduction and their relationship to milk production

871

Sahn-ı Semân’dan Darülfünûn’a Osmanlı İlim ve Fikir Dünyası:Âlimler, Müesseseler ve Fikri Eserler (19. yy)20-21 Aralık 2018

872

SAHN-I SEMÂN’DAN DÂRÜLFÜNÛN’A OSMANLI’DA İLİM VE FİKİR DÜNYASI: ÂLİMLER, MÜESSESELER VE FİKRÎ ESERLER -IİSTANBUL’UN FETHİNDEN SÜLEYMANİYE MEDRESELERİNİN KURULUŞUNA KADAR (İstanbul Üniversitesi İlahiyat Fakültesi, İstanbul, 19-21 Aralık 2014)

873

Sahn-ı Seman’dan Darulfünun’a Osmanlı’da İlim ve Fikir Dünyası: Alimler, Müesseseler ve Fikri Eserler XVIII. Yüzyıl 22-23 Aralık 2017

874

Sahsiah Pelajar Lelaki Lembut: Suatu Persepsi Masyarakat Kampus Universiti Teknologi Malaysia, Skudai, Johor

875

SAI-1: When primary prevention becomes secondary prevention: electron-beam computed tomography screening for coronary disease

876

SAI-10: New use of contrast-enhanced assessment of carotid wall intimal-medial thickness: initial observations

877

SAI-11: WWW.VulnerablePlaque.ORG: prototype of a research-dedicated web site

878

SAI-12: Effect of field of view size on values in coronary artery calcification area, agatston score, and interscan reproducibility of area and score

879

SAI-13: Does 99mTC-sestamibi single-photon emission computed tomography stress testing detect coronary artery disease in patients being evaluated for chest pain?

880

SAI-14: Does electron-beam computed tomography add incremental value to pretest likelihood in predicting abnormal myocardial perfusion single- photon emission computed tomography in asymptomatic patients?

881

SAI-15: Coronary thermosensor basket catheter with thermographic imaging software for thermal detection of vulnerable atherosclerotic plaques

882

SAI-16: pH and lactate imaging of atherosclerotic plaques: introducing a 3-french, 360-degree side-viewing, near-infrared spectroscopic catheter to monitor metabolic activity of atherosclerotic plaque

883

SAI-17: First prototype of a 4-french, 180-degree, side-viewing infrared fiberoptic catheter for thermal imaging of atherosclerotic plaque

884

SAI-18: MRI detection of atherosclerotic vulnerable plaque using superparamagnetic iron oxide contrast media

885

SAI-19: Carotid intima media thickness: relation to cognition

886

SAI-2: Insulin resistance but not β-cell dysfunction is predictive of increased atherosclerosis in asymptomatic individuals without diabetes

887

SAI-20: Coronary calcium scoring with electrocardiographically pulsed multislice spiral computed tomography and reduced radiation exposure

888

SAI-21: Coronary calcifications in “young” patients with first, unheralded myocardial infarction: a risk factor-matched analysis by electron-beam tomography

889

SAI-22: Do cholesterol synthesis enzyme inhibitors influence the progression of coronary calcifications beyond the lipid-lowering effect?

890

SAI-23: Contrast-enhanced electron-beam computed tomography in the evaluation of coronary artery size in patients with coronary artery disease

891

SAI-24: Longitudinal study of lipid-modifying therapies on carotid atherosclerotic plaque morphology in vivo using magnetic resonance imaging

892

SAI-25: Interaction of the paraoxonase genes pon1 and pon2 and the methylenetetrahydrofolate reductase gene and association with coronary artery calcification using electron-beam computed tomography

893

SAI-26: Correlation between calcification of the carotid arteries documented by ultrasound, coronary calcifications in electron-beam tomography, and angiographic coronary artery disease

894

SAI-27: Do patients with diabetes have more diffuse atherosclerotic disease than patients without diabetes, as determined by electron-beam computed tomography?

895

SAI-28: Electron-beam tomography coronary artery calcium scanning: effect of image noise on calibration phantom computed tomography values

896

SAI-29: Association between progression of aortic valve calcification and coronary calcification: a study of electron-beam tomography

897

SAI-3: Rationale and design of the St. Francis Heart Study: a randomized clinical trial of atorvastatin plus antioxidants in asymptomatic persons with elevated coronary calcium

898

SAI-30: Telemedicine system to support percutaneous coronary interventions at a community hospital without on-site cardiac surgery

899

SAI-31: Extracoronary calcium as a marker of extent and severity of coronary atherosclerosis

900

SAI-4: The relation of ankle-brachial pressure to coronary artery calcification in diabetes

901

SAI-5: Dose reduction strategies for electrocardiography gated multislice spiral computed tomography of the heart

902

SAI-6: Pulse wave velocity in normal greek subjects and borderline hypertensive greeks with strong family history of coronary artery disease

903

SAI-7: Validation of the transthoracic echocardiographic measurements of the left anterior descending coronary artery using high-frequency epicardial echocardiography

904

SAI-8: Intensity and patterns of calcium deposition in atherosclerotic plaques of infarct-related coronary artery: an ECG-gated spiral-CT imaging study

905

SAI-9: Quantitation of atherosclerotic plaque burden in the carotid arteries by magnetic resonance imaging

906

Saif Ul Haque Sthapati

907

Saiga antelope calving site selection is increasingly driven by human disturbance

908

Saikachinoside A, a novel 3-prenylated isoguanine glucoside from seeds of Gleditsia japonica

909

SAIL stereo - array isotope labeling

910

SAIL: A School Where the Arts Connect with Real Learning

911

SAIL: Structure-aware indexing for effective and progressive top-k keyword search over XML documents

912

Sailfish (Istiophorus platypterus) spawning and larval environment in a Florida Current frontal eddy

913

SAILHFlood: A radiative transfer model for flooded vegetation

914

SAILHFlood: A radiative transfer model for flooded vegetation

915

Sailing in rough water: market volatility and corporate finance

916

Sailing the Seas of Cheese*

917

sailing through the covid-19 pandemic and beyond: an evidence-based analysis for dental healthcare and practice

918

Sailing virtual canoes across Oceania: revisiting island accessibility

919

Sailor Localization in Oceans Beds using Genetic and Firefly Algorithm

920

SAILOR: a source assisted partial destination slot release scheme for slotted networks

921

SAINS DAN TEKNOLOGI DALAM KETAMADUNAN ISLAM: ANALISA EPISTEMOLOGI DAN METODOLOGI

922

Sains Sosial dan Kajian Pembangunan: Kumpulan Rencana Penghormatan untuk

923

Saint Matthew strikes again: An agent-based model of peer review and the scientific community structure

924

SAINT PAUL PUBLIC WORKS MANAGEMENT

925

SAINT PAUL PUBLIC WORKS MANAGEMENT

926

SAINT VENANTʹS PRINCIPLE AND UNIQUENESS RESULTS IN LINEAR THERMOELASTICITY WITH MEMORY FOR HEAT FLUX

927

Saint-Anthonyʹs Fire

928

SAINTIS DAN PEMBANGUNAN MASYARAKAT: APA SUMBANGAN AL-ZAHRĀWĪ BERASASKAN BUKUNYA ALTASRĪF LI MAN ‘AJIZA ‘AN AL-TA’LĪF ?

929

Saint-Venant decay rates for a non-homogeneous isotropic mixture of elastic solids in anti-plane shear

930

Saint-Venant decay rates for an anisotropic and non-homogeneous mixture of elastic solids in anti-plane shear

931

Saint-Venant decay rates for an inhomogeneous isotropic linear thermoelastic strip

932

Saint-Venant Decay Rates for an Isotropic Inhomogeneous Linearly Elastic Solid in Anti-Plane Shear

933

Saint-Venant end effects for plane deformations of linear piezoelectric solids

934

Saint-Venant End Effects in Anti-plane Shear for Classes of Linear Piezoelectric Materials

935

Saint-Venant end effects in multilayered piezoelectric laminates

936

Saint-Venant end effects in piezoceramic materials

937

Saint-Venant Torsion of a Two-Phase Circumferentially Symmetric Compound Bar

938

Saint-Venant torsion of non-homogeneous anisotropic bars

939

Saint-Venant torsion of orthotropic bars with inhomogeneous rectangular cross section

940

SAINT-VENANT TYPE DECAY ESTIMATES FOR TRANSIENT HEAT CONDUCTION IN A COMPOSITE RIGID SEMISPACE

941

Saint-Venant’s problem for Cosserat shells with voids

942

Saint-Venants principle and the plane elastic wedge

943

SAINT-VENANTʹS PRINCIPLE FOR A MICROPERIODIC COMPOSITE THERMOELASTIC SEMISPACE: THE DYNAMICAL REFINED AVERAGE THEORY

944

SAINT-VENANTʹS PRINCIPLE IN DYNAMIC POROUS THERMOELASTIC MEDIA WITH MEMORY FOR HEAT FLUX

945

Saint-Venantʹs principle in linear isotropic elasticity for incompressible or nearly incompressible materials

946

Saint-Venantʹs Principle in the Asymptotic Analysis of Elastic Rods with One End Fixed

947

Saint-Venantʹs Problem for Porous Linear Elastic Materials

948

SA-IP method for congestion pricing based on level of service in urban network under fuzzy conditions

949

Saiyacenols A and B: the key to solve the controversy about the configuration of aplysiols

950

Saiyutones A–D: four new unusual biflavones from Desmos chinensis

951

952

953

954

955

956

Sak1 kinase interacts with Pso2 nuclease in response to DNA damage induced by interstrand crosslink-inducing agents in Saccharomyces cerevisiae

957

Sakacin Q produced by Lactobacillus curvatus ACU-1: Functionality characterization and antilisterial activity on cooked meat surface

958

SAKE: Software attestation for key establishment in sensor networks

959

Sakiadis flow of an upper-convected Maxwell fluid

960

Sakoli Metallogeny: An Example of Pre-Grenvillian Metal Province from Central India

961

Sako–Wu–Prausnitz equation of state for modelling phase equilibria and high-pressures PVT of mixtures containing dialkyl carbonate and alkane

962

Sakura Science Program 2018: Mendalami Pengalaman Program dan Polisi Berkaitan Penuaan Aktif dan Sihat di Negara Matahari Terbit

963

Sakurais Object, V605 Aquilae, and FG Sagittae: An Evolutionary Sequence Revealed

964

Salad and satiety. The effect of timing of salad consumption on meal energy intake

965

Saladin’s Chivary in Arabic 12th Century Poetry

966

Salafi Sufism in Central Asia and its Future

967

Salafism and Saudi Arabia’s Middle East Policy Towards Iran (2011-2020)

968

Salafiyah Wahabiyah Suatu Penilaian oleh Zamihan Mat Zin al-Ghari

969

SALAK Technique To Buiding Ideas And Sentence Quickly And Effective

970

SALAK technique to buiding ideas and sentence quickly and effective

971

Salalen: a hybrid Salan/Salen tetradentate [ONNO]-type ligand and its coordination behavior with group IV metals

972

973

Salamander scent marks: site of production and their role in territorial defence

974

Salamanders avoid chemical cues from predators

975

Salami pattern formation during phase separation induced by polymerization of 2-chlorostyrene in the presence of polystyrene

976

Salar de Atacama basin: A record of compressional tectonics in the central Andes since the mid-Cretaceous

977

Salaries and Career Opportunities in the Banking Industry: Evidence from the Personnel Records of the Union Bank of Australia

978

Salaries and incomes of health workers in sub-Saharan Africa

979

Salarin C, a new cytotoxic sponge-derived nitrogenous macrolide

980

Salarins D–J, seven new nitrogenous macrolides from the madagascar sponge Fascaplysinopsis sp.

981

Salary Discrimination: A Test of the Paradoxical Female Hypothesis

982

Salary inequality and primary care integration in South Africa

983

Salat And Brainwave Signal Analysis

984

SALBUTAMOL AFFECTS BODY COMPOSITION OF THE GUIEA PIG

985

Salbutamol in the treatment of asthma

986

Salbutamol pretreatment does not change eosinophil percentage and eosinophilic cationic protein concentration in hypertonic saline-induced sputum in asthmatic subjects

987

Salbutamol sulphate-ethylcellulose microparticles: formulation and in-vitro evaluation with emphasis on mathematical approaches

988

Salbutamol treatment of acute severe asthma in the ED: MDI versus hand-held nebulizer

989

Salbutamol-Induced Desensitization and Attempts to Resensitize In Vitro

990

SALE BY NON-REFUNDABLE DEPOSIT (‘ARABUN) AND ITS CONTEMPORARY IMPLEMENTATIONS

991

Sale of Canadian doctorsʹ drug data goes to court

992

Sale of Columbian Chemicals completed

993

Sale of monopoly information and behavior of rivaling clients: A theoretical perspective

994

SALE OF REGULATED ANTIBIOTICS WITHOUT PRESCRIPTION - RESEARCH ON THE PHARMACISTS’ ATTITUDES AND PATTERNS OF ECONOMIC BEHAVIOR

995

SALE SUBJECT TO A CONDITION IN ISLAMIC LAW: A JURISTIC ANALYSIS

996

Salecan diet increases short chain fatty acids and enriches beneficial microbiota in the mouse cecum

997

Salem sets in local fields, the Fourier restriction phenomenon and the Hausdorff–Young inequality

998

Salembierʹs Min-tree algorithm turned into breadth first search

999

Salen and half-salen palladium(II) complexes: synthesis, characteriztion and catalytic activity toward Suzuki–Miyaura reaction

1000

Salen complex of Cu(II) supported on superparamagnetic Fe3O4@SiO2 nanoparticles: An efficient and recyclable catalyst for synthesis of 1- and 5-substituted 1H-tetrazoles

بازگشت